US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 10.800
  • +0.090+0.84%
Close Feb 26 16:00 ET
  • 11.110
  • +0.310+2.87%
Post 19:56 ET
1.10BMarket Cap-1.98P/E (TTM)

Intellia Therapeutics Key Stats

Intellia Therapeutics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
8.10M
+522.52%
EPS
-1.33
+8.64%
Strong Buy

Feb 18, 2025

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.861M--
Feb 27, 20252024/Q4-- / 8.100M--
Nov 7, 20242024/Q39.111M / 7.170M--
Aug 8, 20242024/Q26.957M / 18.277M--
May 9, 20242024/Q128.935M / 9.065M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.861M--
Feb 27, 20252024/Q4-- / 8.100M--
Nov 7, 20242024/Q39.111M / 7.170M--
Aug 8, 20242024/Q26.957M / 18.277M--
May 9, 20242024/Q128.935M / 9.065M--

Unlock Free Earnings Estimates

Intellia Therapeutics Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More